BIOA BIOA R2K
$17.29
+336.62% 1Y
Market & Price
Market Cap
-
Current Price
$17.29
High / Low (52W)
$22.92 / $3.96
Beta
-
Valuation
Stock P/E
-
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
-
Profitability & Returns
ROCE
-29.08%
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
EPS (Latest Qtr)
$-0.52
EPS (TTM)
$-
Balance Sheet & Liquidity
Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$294.89M
Current Assets
$286.79M
Working Capital
$266.65M
Ownership
Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
-
Total Revenue (TTM)
-
EBITDA
-
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Growth (CAGR)
Revenue 5Y
-
Profit 5Y
-34.31%
Revenue (YoY)
-
Earnings (YoY)
-
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Earnings shrank at -34.3% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Ad space
Quarterly Results
Figures in USD.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 0 | - | - | 1.45M | 2.41M | 2.05M | 3.08M | 2.77M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | 17.90M | 27.18M | 25.19M | 31.50M | 28.15M |
| Operating Income | - | - | -9.89M | -12.81M | -15.27M | - | - | -16.45M | -24.77M | -23.14M | -28.42M | -25.38M |
| EBITDA | - | - | - | - | - | - | - | -12.64M | -21.30M | -19.97M | -25.78M | -22.15M |
| Interest Expense | - | - | - | - | - | - | - | 255.00K | 201.00K | 149.00K | 92.00K | 39.00K |
| Pretax Income | - | - | - | - | - | - | - | -12.93M | -21.56M | -20.17M | -25.94M | -22.25M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | -11.08M | -17.19M | -14.62M | -12.99M | -13.58M | - | - | -12.93M | -21.56M | -20.17M | -25.94M | -22.25M |
| Diluted EPS | - | - | -8.74 | -7.76 | -7.94 | -6.70 | - | -0.36 | -0.60 | -0.56 | - | -0.52 |
| R&D Expense | - | - | 6.53M | 9.32M | 10.47M | 20.02M | - | 11.11M | 19.84M | 18.51M | - | 20.41M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 8.99M |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | 39.97M | 48.40M | 78.19M | 101.78M |
| Operating Income | -39.97M | -48.40M | -78.19M | -92.78M |
| EBITDA | -39.35M | -55.90M | -68.58M | -79.69M |
| Interest Expense | 241.00K | 7.79M | 2.37M | 697.00K |
| Pretax Income | -39.72M | -63.85M | -71.11M | -80.61M |
| Tax Provision | - | - | - | - |
| Net Income | -39.72M | -63.85M | -71.11M | -80.61M |
| Diluted EPS | -23.76 | -3.17 | -6.63 | - |
| R&D Expense | - | 33.89M | 59.04M | 73.97M |
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | - |
Compounded Profit Growth
| 5 Years: | -34.31% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +336.62% |
| 6 Months: | +92.11% |
| 3 Months: | -22.36% |
| 1 Month: | +2.55% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | 28.43M | 25.92M | 358.23M | 294.89M |
| Current Assets | 28.03M | 25.31M | 357.10M | 286.79M |
| Cash & Equivalents | 27.64M | 21.64M | 354.35M | 188.89M |
| Inventory | - | - | - | - |
| Receivables | - | - | 0 | 769.00K |
| Total Liabilities | 140.99M | 199.32M | 35.11M | 22.84M |
| Current Liabilities | 5.86M | 58.17M | 27.77M | 20.14M |
| Long Term Debt | 2.25M | 8.20M | 2.50M | - |
| Total Debt | 2.47M | 53.25M | 8.70M | 5.56M |
| Total Equity | -112.56M | -173.40M | 323.13M | 272.05M |
| Shares Outstanding | 34.17M | 34.17M | 35.85M | 37.39M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | -36.18M | -37.36M | -51.52M | -81.63M |
| Investing Cash Flow | -103.00K | -266.00K | -366.00K | -95.22M |
| Financing Cash Flow | 2.50M | 34.94M | 381.20M | 11.47M |
| Capital Expenditure | -103.00K | -166.00K | -366.00K | -719.00K |
| Free Cash Flow | -36.28M | -37.53M | -51.89M | -82.35M |
| Net Change in Cash | -33.78M | -2.69M | 329.31M | -165.37M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | - | - | - | -1,031.5% |
| Net Margin % | - | - | - | -896.1% |
| ROE % | 35.3% | 36.8% | -22.0% | -29.6% |
| ROCE % | -177.1% | 150.1% | -23.7% | -33.8% |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BIOA
No recent headlines available.